GE Healthcare is committed to innovation and connecting every step within molecular imaging to help you make personalised decisions for your patients.
We are focused on providing you with a
TOTAL MI approach - to help you with diagnosis from tracer to treatment - centered on the patient.
If you would like to see more evidence, join us at EANM and attend our extra five satellite symposia on top of the usual industry symposium. They will combine industry trends, physicians' experience and
new products and technologies.
Ben Newton, General Manager Oncology, GE Healthcare
The Future of Precision
Diagnostics - Immune PET
Prof. Rod Hicks, University of Melbourne, Australia
Dr. Simon Williams, D. Phil, Department of Biomedical Imaging, Genentech Inc., USA
Prostate Cancer -
the Role of PSMA PET
Prof. Dr. Karolien Goffin, University Hospital Leuven,
The place of SPECT
Prof. Michael C. Kreissl, University Hospital Magdeburg,
How to Get your Clinic Ready for a Theragnostics Approach